Global prevalence of tigecycline-resistant foodborne Enterobacterales along the food chain: A meta-analysis.

Food Res IntAug 19, 2026 (epub)

Mei Li, Siyue Wang, Kaiyi Zhao et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis evaluated the global prevalence of tigecycline-resistant Enterobacterales in food and food-producing animals, analyzing 104 studies. The overall resistance rate was found to be 4.36%, with E. coli representing 93.01% of resistant strains. The highest resistance was observed at farms (5.05%), particularly in Asia (5.30%).

Key findings

  • The overall prevalence of tigecycline-resistant Enterobacterales was 4.36% (95% CI: 2.83%-6.20%).
  • Among resistant strains, tet(X4) prevalence was 73.81% (95% CI: 43.79%-94.96%).
  • E. coli accounted for 93.01% of the resistant strains identified.
  • The highest resistance rate was found at farms (5.05%), followed by retail markets (2.61%).

Why it matters

The emergence of tigecycline-resistant Enterobacterales poses a significant public health risk, particularly as E. coli is a common pathogen. Understanding resistance patterns can inform strategies to mitigate this threat in the food supply chain.

Source

Published in Food Res Int. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.